Trusted performance. Unmatched versatility.* 

    Improvements to the device delivery system have enabled a 1 Fr profile reduction on the majority of sizes, now offering the most 6 Fr compatible configurations among balloon expandable stent grafts.4-7

    Now 6 Fr compatible

    GREATER VERSATILITY

    UP TO 79 mm

    stent length4-7


      Darren Schneider, M.D., Andrew Holden, M.D., Bill Gray, M.D. and Venita Chandra, M.D. discuss benefits of the reduced profile VBX Stent Graft. 

      Trusted procedural and clinical performance 

      100% restoration

      of lumen diameter2

      Before and after x-ray


      ≤ 30% residual stenosis due to high radial strength, even in highly calcified and non-compliant lesions 

      vbx-graphic-pre-deployment

      100%

      maintenance of stent length2

      Median length change was 0 mm, predeployed to final implant 

      vbx-graphic-post-deployment
      • 100% delivery to target lesion with no device dislodgement2,‡
      • 100% stent retention2,‡
      • 100% deployment at the target site2,‡
      • 234 devices delivered
        • 50% bilateral treatment
        • 42% kissing stents
        • 32% TASC II C & D including occlusions
        • 18% contralateral deliveries
        • Predilatation not required

      94.5%

      1-year primary patency1

      91.2%

      freedom from target lesion revascularization (fTLR) at 3 years1

      89.5%

      primary patency per lesion through 5 years3

      Black Charcoal
      Black Charcoal
      Black Charcoal
      /Technology

      Dedicated to Innovation: Thromboresistance in Vascular Devices

      Learn more about CBAS® Heparin Surface
      Learn more
      Blue stone
      Blue stone
      Blue stone
      /Peripheral portfolio

      Innovation for improved outcomes in complex peripheral disease

      Gore's innovative solutions are designed for treating complex peripheral disease and backed by dedicated service to help improve patient outcomes.
      Learn more


        Animation - GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis


          Kissing stents conformability

          Related to this product

          * Across indication inclusivity and configuration breadth/capability of balloon expandable covered stents.
          † Complex defined as TASC II classification C & D lesions.
          ‡ Procedural outcomes based on usage of legacy GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis. (BXA catalogue numbers).

          1. Panneton JM, Bismuth J, Gray BH, Holden A. Three-year follow-up of patients with iliac occlusive disease treated with the Viabahn Balloon-Expandable Endoprosthesis. Journal of Endovascular Therapy 2020;27(5):728-736.
          2. Bismuth J, Gray BH, Holden A, Metzger C, Panneton J; VBX FLEX Study Investigators. Pivotal study of a next-generation balloon-expandable stent-graft for treatment of iliac occlusive disease. Journal of Endovascular Therapy 2017;24(5):629-637. http://journals.sagepub.com/doi/full/10.1177/1526602817720463.
          3. Holden A, Takele E, Hill A, et al. Long-term follow-up of subjects with iliac occlusive disease treated with the Viabahn VBX Balloon-Expandable Endoprosthesis. Journal of Endovascular Therapy. In press. 
          4. GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Instructions for Use (IFU). W. L. Gore & Associates, Inc. Accessed October 18, 2024. https://eifu.goremedical.com/
          5. LIFESTREAM® Balloon Expandable Vascular Covered Stent [Instructions for Use]. Tempe, AZ: Bard Peripheral Vascular, Inc; 2019. BAW1345700 Rev. 5 06/19
          6. iCast covered stent system [Instructions for Use]. Merrimack, NH: Atrium Medical Corporation; 2023. AW009603-EN Rev 11.
          7. Advanta V12 Balloon Expandable Covered Stent [Instructions for Use]. Merrimack, NH; Getinge AB. https://www.getinge.com/int/products/advanta-v12-balloon-expandable-covered-stent 
          IFU Consult instructions

          Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

          INDICATIONS FOR USE IN THE U.S.: The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5 mm–13 mm and lesion lengths up to 110 mm, including lesions at the aortic bifurcation. The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is also indicated for use with thoracoabdominal and pararenal branched devices indicated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as a branch component.§

          CONTRAINDICATIONS: Do not use the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.  

          § Not applicable to Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis. (BXB catalogue numbers). 

          The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is not authorized for use with thoracoabdominal and pararenal branched devices indicated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as a branch component in Canada.

          24PL1105-EN02